RVG-Modified BMSCs-Derived Small Extracellular Vesicles Loaded With miR-21 Alleviate Neuronal Injury Resulted From Excessive Autophagy via Targeting PTEN/Akt/mTOR Pathway After Cerebral Ischaemia.

Overview

1. State Key Laboratory of Mechanism and Quality of Chinese Medicine, University of Macau, Taipa, Macau SAR, China
2. Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau SAR, China
3. Guangdong Institute of Intelligence Science and Technology, Zhuhai, Guangdong, China
4. College of Pharmacy, Shenzhen Technology University, Shenzhen, Guangdong, China

Abstract

Ischaemic stroke (IS) leads to tragic disability and high adult mortality, while there are limited therapeutic measures for it. Small extracellular vesicles (sEVs) derived from bone marrow mesenchymal stem cells (BMSCs) have been suggested to have satisfactory therapeutic effects on IS by the delivery of their packed microRNA (miRNA). However, systematically administered naïve sEVs are difficult to cross the blood‐brain barrier (BBB) and enter the brain parenchyma; also, the low abundance of sEVs cargo miRNAs restricts the possibility of maximising their regulatory functions. Hence, the brain targeting modification and miRNA delivery strategy are crucial for the optimisation of BMSC‐sEVs therapeutic effects. In this study, based on sEVs miRNA‐seq and analysis of the RNA‐seq datasets for ischaemic stroke patients’ samples in the GEO database, we identified that miR‐21 sharply drops in the ischaemic brain. By the bioengineered BMSCs with RVG‐Lamp2b peptide and miR‐21‐5p overexpression plasmid, RVG‐miR21‐sEVs were successfully developed. After characterisation of RVG‐miR21‐sEVs, it showed that RVG‐modified sEVs had a high affinity to neurons, and the administration of RVG‐miR21‐sEVs displayed superior neurological functional rehabilitation and cerebral infarction reduction in the mouse transient middle cerebral artery occlusion (tMCAo) model. Additionally, RVG‐miR21‐sEVs treatment suppressed neuron autophagy, mitochondria dysfunction and apoptosis after oxygen‐glucose deprivation/re‐oxygenation (OGD/R) insult. Furthermore, by using dual‐luciferase reporter assay, FISH technique, and miR‐21 inhibitor and mimics transfection, we validated that the target of miR‐21 is PTEN, and the mechanism investigation showed that miR‐21 targets the PTEN/Akt/mTOR pathway to antagonise neuronal injury due to excessive autophagy.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

• geo:GSE86291, at NCBI GEO; found in the text, “miRNA Sequencing and GEO Database Analysis”

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 10 authors, 5 keywords, 14 MeSH terms, 2 funders, 59 references.

Cite

This paper

Li, Y., Hu, J., Chen, J., Zhou, M., Liao, M., Yang, Y., Zhou, J., Han, Y., Wang, B., & Zhao, Y. (2026). RVG-Modified BMSCs-Derived Small Extracellular Vesicles Loaded With miR-21 Alleviate Neuronal Injury Resulted From Excessive Autophagy via Targeting PTEN/Akt/mTOR Pathway After Cerebral Ischaemia. Journal of extracellular vesicles, 15(5), e70295. https://doi.org/10.1002/jev2.70295

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1097/md.0000000000048634

Identifying therapeutic target genes for stroke through systematic druggable Mendelian randomization analysis.

Journal: Medicine

In common: stroke, cellular / molecular, 3 references

[2] doi:10.1016/j.isci.2026.115779

Propranolol alleviates cerebral infarction through the β2-AR-mediated ERK/NLRP3 pathway.

Journal: iScience

In common: stroke, mouse, cellular / molecular, 2 references

[3] doi:10.1007/s43440-026-00866-2

Selective non-nuclear estrogen receptor activation with PaPE-1 evokes neuroprotection involving mTOR/MEK in an in vitro model of hypoxic/ischemic injury.

Journal: Pharmacological reports : PR

In common: stroke, mouse, cellular / molecular, 2 references

[4] doi:10.1002/advs.77053

Extracellular CIRP Dysregulates Microglial Efferocytosis in Acute Ischemic Stroke via the TLR4/miR-155/MafB Axis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

In common: stroke, mouse, cellular / molecular, 2 references

[5] doi:10.1136/svn-2025-004248

Brain-targeted extracellular vesicles for anti-cuproptosis therapy in subarachnoid haemorrhage.

Journal: Stroke and vascular neurology

In common: stroke, mouse, 2 references

[6] doi:10.3389/fmolb.2026.1844734

Discovery and validation of programmed cell death-associated key biomarker genes in ischemic stroke via ssGSEA/WGCNA and LASSO-SVM-RFE.

Journal: Frontiers in molecular biosciences

In common: stroke, 2 references

[7] doi:10.1111/acel.70470

Serum-Derived Extracellular Vesicles as Biological Indicator of Mobility Resilience in Older Adults.

Journal: Aging cell

In common: cellular / molecular, 2 references

[8] doi:10.1186/s12929-026-01271-w

Lack of cortistatin drives neuroimmune and vascular dysfunction in brain ischemia.

Journal: Journal of biomedical science

In common: stroke, mouse, cellular / molecular, 1 reference

[9] doi:10.1038/s41419-026-09021-4

ACLY alleviates cerebral ischemia/reperfusion injury by reducing oxidative stress and enhancing mitochondrial function via histone acetylation.

Journal: Cell death & disease

In common: stroke, mouse, cellular / molecular, 1 reference

[10] doi:10.1002/jnr.70130

Pantothenic Acid Protects Neurons After Ischemic Stroke by Targeting ID3 to Restore Action Potential Amplitude.

Journal: Journal of neuroscience research

In common: stroke, mouse, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.